In this presentation from the Immunotherapy Session at the 2018 Great Debates & Updates in Gastrointestinal Malignancies, Dr. Scott Kopetz assesses whether or not we presently have reliable biomarkers that can be leveraged for the use of immunotherapy agents.
Earn CME Credit for this activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=7292
© 2018 Imedex, LLC.
Advertisement